Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis. [PDF]
Jin M, Shi P, Yu Y.
europepmc +1 more source
Vascular transcriptional and metabolic changes precede progressive intrarenal microvascular rarefaction in autosomal dominant polycystic kidney disease. [PDF]
Yilmaz G +11 more
europepmc +1 more source
Effect of tolvaptan on the prognosis of patients with rapidly progressive autosomal dominant polycystic kidney disease: a prospective open-label study. [PDF]
Zhou L, Li W.
europepmc +1 more source
Abnormal purinergic signaling contributes to development of renal cysts in autosomal dominant polycystic kidney disease. [PDF]
Ivanov V +9 more
europepmc +1 more source
Kidney stones and autosomal dominant polycystic kidney disease: a state-of-the-art review. [PDF]
Borghol AH +19 more
europepmc +1 more source
Genetic testing in autosomal dominant polycystic kidney disease: why it matters in 2025. [PDF]
Cornec-Le Gall E, Ong ACM.
europepmc +1 more source
Clinical Factors Associated With Intracranial Aneurysms in Patients With Autosomal Dominant Polycystic Kidney Disease. [PDF]
Fuchinoue Y +7 more
europepmc +1 more source
Quantitative dynamic contrast-enhanced magnetic resonance imaging for renal perfusion measurement in autosomal dominant polycystic kidney disease. [PDF]
Onuoha EE +4 more
europepmc +1 more source

